ArticleClinical drug investigation2025

Comment on: "Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E‑Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations".

Claire Watkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.